Dora Menchaca
Impact in
- Hematology top 1%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Platelet Disorders and Treatments 6
- Hematopoietic Stem Cell Transplantation 5
- Blood groups and transfusion 3
- Oncology 4
- Neutropenia and Cancer Infections 3
- Inflammatory Biomarkers in Disease Prognosis 1
- Co-authors
- Russell L. Basser (3 shared papers)C. Glenn Begley (2 shared papers)Brian M. Cohen (2 shared papers)Dianne Tomita (2 shared papers)William Sheridan (4 shared papers)John A. Glaspy (3 shared papers)Jonathan Cebon (3 shared papers)Richard M. Fox (2 shared papers)
- Journals
- Blood (3 papers)Stem Cells (1 paper)Journal of Clinical Oncology (1 paper)The Journal of Clinical Pharmacology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Dora Menchaca
11 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 71
- Hematology 816
- Genetics 211
- Immunology 245
- Immunology and Allergy 65
- Oncology 194
Countries citing papers authored by Dora Menchaca
This map shows the geographic impact of Dora Menchaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Menchaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Menchaca more than expected).
Fields of papers citing papers by Dora Menchaca
This network shows the impact of papers produced by Dora Menchaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Menchaca. The network helps show where Dora Menchaca may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Menchaca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 210 | |
| 2 | 1996 | 209 | |
| 3 | 2002 | 191 | |
| 4 | 1996 | 163 | |
| 5 | 1997 | 149 | |
| 6 | 1997 | 124 | |
| 7 | 1998 | 27 | |
| 8 | 2002 | 24 | |
| 9 | 2004 | 18 | |
| 10 | 1994 | 6 | |
| 11 | 1998 | 1 |
About Dora Menchaca
Dora Menchaca is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Cell Biology, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Blood groups and transfusion (3 papers), Neutropenia and Cancer Infections (3 papers), Ovarian function and disorders (1 paper), Mast cells and histamine (1 paper), Blood disorders and treatments (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Hematology (816 citations), Genetics (211 citations), Immunology (245 citations), Immunology and Allergy (65 citations) and Oncology (194 citations). Dora Menchaca has collaborated with scholars based in United States and Australia. Frequent co-authors include Russell L. Basser, C. Glenn Begley, Brian M. Cohen, Dianne Tomita, William Sheridan, John A. Glaspy, Jonathan Cebon, Richard M. Fox, Michael D. Green and Kerrie Clarke. Their work appears in journals such as Blood, Stem Cells, Journal of Clinical Oncology, The Journal of Clinical Pharmacology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.